troglitazone has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reddy, RC | 2 |
| Srirangam, A | 1 |
| Reddy, K | 1 |
| Chen, J | 1 |
| Gangireddy, S | 1 |
| Kalemkerian, GP | 1 |
| Standiford, TJ | 2 |
| Keshamouni, VG | 2 |
| Arenberg, DA | 1 |
| Newstead, MJ | 1 |
| Anthwal, S | 1 |
| Li, M | 1 |
| Lee, TW | 1 |
| Yim, AP | 1 |
| Mok, TS | 1 |
| Chen, GG | 1 |
3 other studies available for troglitazone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromans; Gene Exp | 2008 |
PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
Topics: Amino Acid Motifs; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Ce | 2005 |
Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Differentiation; Cell Nucleus; Chromans; C | 2006 |